retatrutide for menopause vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide for Women: Safety, Results

Discontinuation rates due to adverse effects were higher in the higher-dose groups, which is an important consideration for tolerability in clinical practice

Which has better muscle preservation, CagriSema or tirzepatide

Conclusion GLP-1 medications represent a major advancement in the treatment of type 2 diabetes and obesity

When taken together, Defend and Amplify deliver a dual-action approach helping tame inflammaging while energizing your metabolismto help you feel vibrant, balanced, and in control

Regional Trends: North America is expected to retain a dominant share of the GLP-1 peptide synthesis CDMO market throughout the forecast period, supported by its well-established pharmaceutical manufacturing infrastructure, robust regulatory framework, and substantial clinical demand for GLP-1-based therapies

Handa, Victoria L et al